- Home
- BAX vs CHRW Comparison
BAX vs CHRW Comparison
Compare BAX & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | CHRW |
|---|---|---|
| Founded | 1931 | 1905 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 17.7B |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | BAX | CHRW |
|---|---|---|
| Price | $18.60 | $156.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 22 |
| Target Price | $25.67 | ★ $137.86 |
| AVG Volume (30 Days) | ★ 8.3M | 1.4M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | 0.22% | ★ 1.60% |
| EPS Growth | N/A | ★ 70.68 |
| EPS | N/A | ★ 4.94 |
| Revenue | $11,023,000,000.00 | ★ $16,504,785,000.00 |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $2.02 | $3.08 |
| P/E Ratio | ★ N/A | $31.86 |
| Revenue Growth | ★ 3.90 | N/A |
| 52 Week Low | $17.40 | $84.68 |
| 52 Week High | $37.74 | $162.79 |
Technical Indicators
Market Signals| Indicator | BAX | CHRW |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 62.89 |
| Support Level | $18.33 | $158.37 |
| Resistance Level | $19.17 | $162.79 |
| Average True Range (ATR) | 0.54 | 3.24 |
| MACD | 0.21 | -0.36 |
| Stochastic Oscillator | 63.23 | 60.86 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.